secwatch.observer — SEC 8-K summary
======================================

Issuer:     Boundless Bio, Inc. (BOLD)
CIK:        0001782303
Form:       8-K
Filed at:   2024-04-02T23:59:59+00:00
Accession:  0001193125-24-084736
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Boundless Bio completes IPO of 6.25M shares at $16.00, raising $100M gross
--------------------------------------------------------------------------

- IPO closed April 2, 2024; 6,250,000 shares sold at $16.00 per share.
- Gross proceeds of $100.0 million before underwriting discounts and expenses.
- Amended charter increases authorized common to 700M shares, authorizes 70M preferred shares.
- Board classified into three classes with staggered three-year terms; removal only for cause with 2/3 vote.
- Stockholder action by written consent eliminated; exclusive forum provisions adopted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782303/000119312524084736/0001193125-24-084736-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782303/000119312524084736/d796750d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-084736

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer